Update for customers, suppliers, and governments
Our efforts to address COVID-19
Cytiva’s number one priority is the health and safety of our employees and our customers. We are working closely with local governments, the World Health Organization (WHO), and U.S. Centers for Disease Control (CDC) to actively monitor the outbreak and take all necessary precautions. We are prepared to walk alongside our customers to help ensure continuity of business, stay connected virtually for support, and provide solutions in this time of need.
Security of supply
Cytiva has comprehensive crisis management and security of supply programs in place. We are committed to fulfilling customer orders and regularly adjust our manufacturing output to respond to market demands, while ensuring our operations and service capabilities continue safely. We are also in regular contact with our suppliers regarding their business continuity plans to help minimize disruption of the flow of materials into our manufacturing facilities.
We understand that you may have concerns about your service orders. Please know we are committed to fulfilling service orders, while ensuring our operations continue safely. However, with such a dynamic situation, please be aware that this situation may change, and we will keep you informed of material developments.
The COVID-19 crisis has brought together the scientific community like never before. Our global team is helping to accelerate the work of researchers, developers, and manufacturers of diagnostics and vaccines, to bring access to much-needed solutions for COVID-19.
- Genedrive: PCR assay to detect SARS-CoV-2
- Sona Nanotech: rapid response lateral flow test
- Avacta: Affimer-based point-of-care rapid screening test
- Entos Pharmaceuticals: downstream purification method for protein-based vaccine
- Takara Bio: plasmid vaccine
- Aptamer Group: rapid response lateral flow test
Diagnostic assay development
In response to COVID-19, many diagnostic laboratories and test developers are urgently working to design, manufacture, and validate assays. With over 40 years of experience in diagnostics, we are here to support you from product concept to commercialization. Explore solutions to help develop and manufacture your COVID-19 detection assay, from molecular diagnostics to lateral flow immunoassays.
Vaccine manufacture can have its challenges, from purification to production scale-up. Increase your opportunity to address vaccine manufacturing needs for COVID-19 and other infectious diseases. Explore manufacturing process strategies based on flexible single-use technologies that can help enhance productivity, resulting in more cost-efficient scalable processes, and reduced timelines.
Connect with us virtually
We recognize that travel restrictions and cancelled events can limit in-person meetings. If you have a meeting scheduled, we will be happy to transition to a virtual option as tools and technology allow. Content from onsite activities has been converted to online events and will be announced on LinkedIn, Twitter, Facebook, and email. Connect with us to have access to the latest news, education, and events.
Support and expertise
We’re committed to making sure you can continue your important work during the situation with COVID-19. Please contact us with any questions that you may have, whether product, service, or support related. We will put you in touch with the proper contact to help provide an answer to your question in a timely manner.